The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
What Is 12.5mg Mounjaro and How Does It Work?
12.5mg Mounjaro is the second-highest available dose of tirzepatide, a prescription-only weight management injection licensed in the UK. At this dose level, Mounjaro may help support weight loss by activating dual GIP and GLP-1 hormone pathways, which can reduce appetite and help you feel fuller after smaller meals. The 12.5mg dose is typically reached after several weeks of dose escalation from the starting 2.5mg. Most people don't reach this dose immediately—your prescriber will increase your dose gradually based on how well you tolerate the injection and your progress. Understanding what happens at the 12.5mg stage helps you know what to expect in your weight management journey.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How the 12.5mg Dose Fits Into Your Treatment Journey
Mounjaro comes as a once-weekly injection delivered via a pre-filled KwikPen. The 12.5mg dose is part of a structured escalation schedule that typically looks like this: 2.5mg for weeks 1–4, then 5mg for weeks 5–8, 7.5mg for weeks 9–12, 10mg for weeks 13–16, and finally 12.5mg from week 17 onwards. You must spend at least 4 weeks on each dose before increasing further. This gradual approach helps your body adapt and allows your prescriber to monitor how you're responding. At 12.5mg, the dual GIP and GLP-1 mechanism is operating at a substantial level—stronger than lower doses but still below the maximum 15mg. Clinical data suggests that weight loss effects typically continue to increase with dose escalation, though individual results vary significantly. Many people experience noticeable appetite reduction and improved satiety (feeling of fullness) at this dose level, though some may have already reached their target weight at lower doses.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Side Effects and What to Monitor at 12.5mg
Side effects at 12.5mg are generally similar to those at lower doses, though some people report them becoming more pronounced. Very common side effects include nausea, diarrhoea, constipation, and stomach pain. These typically improve over time as your body adjusts, but they can persist for some people. Less commonly, you may experience headache, fatigue, injection site reactions (redness or bruising), or changes in appetite perception. If you experience severe stomach pain that spreads to your back, seek urgent medical attention as this could indicate pancreatitis. Hair loss and changes in taste have also been reported by some users. Keep a record of how you feel at each dose using our free progress tracker, and report any concerning symptoms to your prescriber. Most side effects are manageable, but your GP or prescriber should always be your first point of contact if you're concerned.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is 12.5mg Mounjaro the maximum dose available?
No. The maximum dose is 15mg per week. 12.5mg is the second-highest dose. Some people reach 15mg if they tolerate it well and their prescriber judges it appropriate. Not everyone needs to escalate to the highest dose—your prescriber will assess what works best for you based on your individual response and health goals.
How much weight loss might I expect at 12.5mg Mounjaro?
Clinical trial data from the SURMOUNT studies showed average weight loss of around 15–21% of body weight across all doses. At 12.5mg specifically, results vary widely depending on your individual metabolism, diet, and activity level. Some people lose significant weight; others lose more modest amounts. Always use our GLP-1 weight loss calculator to get a personalised estimate based on your starting weight, but remember individual results vary considerably.
Can I jump straight to 12.5mg, or do I have to start at 2.5mg?
You must start at 2.5mg and escalate gradually. This is a mandatory schedule built into UK prescribing guidelines. Starting low allows your prescriber to assess how you tolerate the injection and helps minimise side effects. Jumping to a higher dose would be unsafe and is not recommended. The 4-week intervals between doses are essential for monitoring and safety.
What's the difference between 12.5mg Mounjaro and 12.5mg Wegovy?
Wegovy (semaglutide) doesn't have a 12.5mg dose—its maximum is 2.4mg. Mounjaro has a dual GIP and GLP-1 mechanism, while Wegovy is a GLP-1-only medication. If you're comparing doses, Mounjaro 12.5mg is roughly equivalent to Wegovy's maximum 2.4mg dose in terms of strength, though they work slightly differently. Any switch between medications must be managed by your prescriber.
How do I get prescribed 12.5mg Mounjaro in the UK?
You'll need a prescription from a UK-licensed healthcare professional following a clinical assessment. This is available through NHS specialist weight management services (tier 3) if you're eligible and referred, or through private online prescribing following an online consultation. Your prescriber must assess your BMI, health conditions, and suitability before issuing a prescription. The tirzepatide KwikPen is then dispensed by a registered pharmacy.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.